{"SPECIMEN TYPE": "SPECIMEN TYPE Block", "SPECIMEN SITE": "SPECIMEN SITE Skin", "DATE OF COLLECTION": "DATE OF COLLECTION 13 May 2021", "REPORT DATE": "21 Jun 2021", "Biomarker Findings": ["Microsatellite status - MS-Stable", "Tumor Mutational Burden - o Muts/Mb", ""], "Genomic Findings": ["For a complete list of the genes assayed, please refer to the Appendix.", "BRAF V600E", "CDKN2A/B p16INK4a V82fs*44 and p14ARF R96fs*71", "MLL2 D2769N", "TERT promoter -124C>T", ""], "Microsatellite status - MS-Stable": [["Dabrafenib", "+ Trametinib", "Encorafenib +", "Binimetinib", "Vemurafenib +", "Cobimetinib", "Dabrafenib", "Vemurafenib", "Vemurafenib +", "Cobimetinib +", "Atezolizumab", "Trametinib", "p. 5"], ["Selumetinib", "NCCN category"]]}